My watch list
my.chemeurope.com  
Login  

Fresenius SE



Fresenius SE
Public
Founded1912
Headquarters Bad Homburg, Germany
Key peopleUlf M. Schneider (Chairman of the management board), Gerd Krick (Chairman of the supervisory board)
IndustryHealth care
ProductsKidney dialysis
Infusion pumps and drugs
hospitals
medical care of patients at home
Revenue€10.777 billion (2006)[1]
Employees104,800 (2006)[1]
Websitewww.fresenius.se

Fresenius SE (FWB: FREG) is a health care company with approximately 100,000 employees, based in Bad Homburg, Germany.

Fresenius consists of three wholly-owned business units, Fresenius Biotech, Fresenius Kabi and Fresenius ProServe, and holds approximately 37% of Fresenius Medical Care.[2]

The American branch is headquartered in Waltham, Massachusetts.

On 2007-07-16, the company completed its conversion from an aktiengesellschaft (German public limited company) to a Societas Europaea, a European Union-wide equivalent.[3]

References

  1. ^ a b Fresenius SE. Fresenius Annual Report 2006. Retrieved on 2007-08-12.
  2. ^ Fresenius Medical Care. Capital structure. Retrieved on 2007-08-12.
  3. ^ Fresenius SE (2007-07-16). Fresenius completes conversion into a European Company (SE). Retrieved on 2007-08-12.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fresenius_SE". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE